Stop Patient Drop Out, Before It Starts
By Kyle Cunningham, Chief Product Officer

Patients participating in clinical trials receive benefits in addition to potentially receiving breakthrough drugs and devices. Trial enrollees also receive state of the art care and additional monitoring. However, extra monitoring does not come without additional burdens. Patients must typically make additional trips to a research site compared to traditional care, incurring costs from transportation, parking, meals, and may need to take time off work, and subsequent childcare.
A staggering 30% of patients drop out of clinical studies prematurely. Inconvenient study locations, sometimes inconsistent communication from sites to patients, and overly onerous time commitments, all play a role in attrition; however, these non-medical obstacles can be overcome.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.